The state is taking action against three major drug companies and the big pharmacy benefit managers in an effort to temper costs for people with diabetes.
Author: BENJAMIN RYAN
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}